JENNIFER GRIFFIS: Open Payments
NPI 1134545791 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 22 payments from 9 companies in 2025. Trend: 2023 $1,201 · 2024 $867 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| ABBVIE INC. | 3 | $50 |
| Novo Nordisk Inc | 3 | $49 |
| Amgen Inc. | 2 | $36 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| SCILEX PHARMACEUTICALS INC. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: NURTEC ODT, FARXIGA, XIFAXAN, OTEZLA, QULIPTA, Wegovy, RELISTOR, BREZTRI.
Industry payments across AL — which companies pay providers there.
